Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Transplant Cell Ther ; 27(10): 807-816, 2021 10.
Article in English | MEDLINE | ID: mdl-34107340

ABSTRACT

The fifth annual Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma was conducted as one of the American Society of Hematology Annual Meeting Scientific Workshops on Thursday December 3, 2020. This workshop focused on four main topics: (1) integrating minimal residual disease into clinical trial design and practice; (2) the molecular and immunobiology of disease evolution and progression in myeloma; (3) adaptation of next-generation sequencing, next-generation flow cytometry, and cytometry by time of flight techniques; and (4) chimeric antigen receptor T-cell and other cellular therapies for myeloma. In this report, we provide a summary of the workshop presentations and discuss future directions in the field.


Subject(s)
Multiple Myeloma , Humans , Bone Marrow , Diterpenes , High-Throughput Nucleotide Sequencing , Multiple Myeloma/diagnosis , Neoplasm, Residual
SELECTION OF CITATIONS
SEARCH DETAIL
...